Dare Bioscience, Inc. Warrant, Exercise Price, Decrease
Dare Bioscience, Inc. (DARE) reported Warrant, Exercise Price, Decrease of $11.52 per share for the 1-month period ending 2020-07-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:WarrantExercisePriceDecrease · last filed 2025-03-31
- 2020-07-31: Warrant, Exercise Price, Decrease 1 month $11.52; Warrant, Exercise Price, Decrease 1 month as first filed $0.96.
- 2019-04-30: Warrant, Exercise Price, Decrease 1 month $11.76; Warrant, Exercise Price, Decrease 1 month as first filed $0.98.
| Period end | Warrant, Exercise Price, Decrease 1 month | Warrant, Exercise Price, Decrease 1 month as first filed |
|---|---|---|
| 2020-07-31 | $11.52 10-K · filed 2025-03-31 | $0.96 10-Q · filed 2020-11-12 |
| 2019-04-30 | $11.76 10-K · filed 2025-03-31 | $0.98 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |